457945953	457945953	CD	B-NP	O
|	|	JJ	I-NP	O
M	M	NN	I-NP	O
|	|	NN	I-NP	O
04369147	04369147	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
641434	641434	CD	B-NP	O
|	|	CC	I-NP	O
9/18/1997	9/18/1997	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
ATRIAL	ATRIAL	NNP	I-NP	I-protein
FIBRILLATION	FIBRILLATION	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/18/1997	9/18/1997	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/14/1997	10/14/1997	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CHEST	CHEST	NN	B-NP	O
PAIN	PAIN	NN	I-NP	O
AND	AND	NN	I-NP	O
PRESYNCOPE	PRESYNCOPE	NN	I-NP	O
.	.	.	O	O

SECONDARY	SECONDARY	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
HYPERTENSION	HYPERTENSION	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
ELEVATED	ELEVATED	NN	I-NP	O
CHOLESTEROL	CHOLESTEROL	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
3	3	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
CORONARY	CORONARY	NN	I-NP	O
ARTERY	ARTERY	NN	I-NP	O
DISEASE	DISEASE	NN	I-NP	O
STATUS	STATUS	NN	I-NP	O
POST	POST	NN	I-NP	O
CORONARY	CORONARY	NN	I-NP	O
ARTERY	ARTERY	NN	I-NP	O
BYPASS	BYPASS	NN	I-NP	O
GRAFT	GRAFT	NN	I-NP	O
SURGERY	SURGERY	NN	I-NP	O
ON	ON	NN	I-NP	O
10/13/97	10/13/97	CD	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
STATUS	STATUS	NN	I-NP	O
POST	POST	NN	I-NP	O
BLADDER	BLADDER	NN	I-NP	O
SUSPENSION	SUSPENSION	NN	I-NP	O
SURGERY	SURGERY	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
5	5	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
PAROXYSMAL	PAROXYSMAL	NN	I-NP	O
ATRIAL	ATRIAL	NN	I-NP	O
FIBRILLATION	FIBRILLATION	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
72-year-old	72-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
on	on	IN	B-PP	O
2/9/97	2/9/97	CD	B-NP	O
for	for	IN	B-PP	O
bladder	bladder	NN	B-NP	O
suspension	suspension	NN	I-NP	O
surgery	surgery	NN	I-NP	O
to	to	TO	B-PP	O
Tion	Tion	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
The	The	DT	B-NP	O
plan	plan	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
laparoscopic	laparoscopic	JJ	I-NP	O
procedure	procedure	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
bladder	bladder	NN	B-NP	O
puncture	puncture	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
converted	convert	VBN	I-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
open	open	JJ	I-NP	O
procedure	procedure	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
ST	ST	JJ	B-NP	O
depressions	depression	NNS	I-NP	O
on	on	IN	B-PP	O
EKG	EKG	NN	B-NP	B-protein
intraoperatively	intraoperatively	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ICU	ICU	NN	I-NP	B-DNA
there	there	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
and	and	CC	O	O
developed	develop	VBD	B-VP	O
postmyocardial	postmyocardial	JJ	B-NP	O
angina	angina	NN	I-NP	O
with	with	IN	B-PP	O
EKG	EKG	NN	B-NP	O
changes	change	NNS	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
unrelieved	unrelieved	JJ	B-ADJP	O
by	by	IN	B-PP	O
sublingual	sublingual	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
this	this	DT	B-NP	O
reason	reason	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
IV	IV	CD	B-NP	O
TNG	TNG	NN	I-NP	O
and	and	CC	O	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
Mead	Mead	NNP	B-NP	O
Ry	Ry	NNP	I-NP	O
`	`	``	O	O
sweeks	sweek	VBZ	B-VP	O
Hospital	Hospital	NNP	B-NP	O
And	And	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
on	on	IN	B-PP	O
1/10/97	1/10/97	CD	B-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
revealed	reveal	VBD	B-VP	O
three	three	CD	B-NP	O
vessel	vessel	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
grafting	graft	VBG	B-VP	O
on	on	IN	B-PP	O
3/4/97	3/4/97	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
LIMA	LIMA	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
,	,	,	O	O
SVG	SVG	NN	B-NP	O
to	to	TO	B-PP	O
PDA	PDA	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
SVG	SVG	NN	B-NP	B-protein
to	to	TO	B-PP	O
OM1	OM1	NN	B-NP	B-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
postoperative	postoperative	JJ	I-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
paroxysmal	paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
symptomatic	symptomatic	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
procainamide	procainamide	NN	B-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
1/4/97	1/4/97	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
subtherapeutic	subtherapeutic	JJ	I-NP	O
proc/nepa	proc/nepa	NN	I-NP	O
level	level	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
3.0-4	3.0-4	CD	I-NP	O
.5	.5	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
arrived	arrive	VBD	B-VP	O
home	home	NN	B-ADVP	O
at	at	IN	B-PP	O
4	4	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
and	and	CC	O	O
felt	feel	VBD	B-VP	O
well	well	RB	B-ADVP	O
until	until	IN	B-PP	O
approximately	approximately	RB	B-NP	O
7	7	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
acute	acute	JJ	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
8	8	CD	B-NP	O
out	out	IN	I-NP	O
of	of	IN	I-NP	O
10	10	CD	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
across	across	IN	B-PP	O
her	her	PRP$	B-NP	O
entire	entire	JJ	I-NP	O
chest	chest	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
down	down	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
arm	arm	NN	I-NP	O
and	and	CC	O	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
light-headedness	light-headedness	NN	B-NP	O
and	and	CC	O	O
visual	visual	JJ	B-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reported	report	VBD	B-VP	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
prior	prior	JJ	I-NP	O
anginal	anginal	JJ	I-NP	O
episode	episode	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
took	take	VBD	B-VP	O
three	three	CD	B-NP	O
sublingual	sublingual	JJ	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
relief	relief	NN	I-NP	O
.	.	.	O	O

EMTs	EMT	NNS	B-NP	O
were	be	VBD	B-VP	O
called	call	VBN	I-VP	O
and	and	CC	O	O
found	find	VBN	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
pale	pale	NN	I-NP	O
,	,	,	O	O
diaphoretic	diaphoretic	JJ	B-ADJP	O
,	,	,	O	O
with	with	IN	B-PP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
90/palp	90/palp	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
150	150	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
more	more	JJR	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
and	and	CC	O	O
improved	improve	VBN	B-VP	O
somewhat	somewhat	RB	B-ADVP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
Aen	Aen	NNP	B-NP	O
Er/in	Er/in	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
where	where	WRB	B-ADVP	O
EKG	EKG	NNP	B-NP	O
showed	show	VBD	B-VP	O
rapid	rapid	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
ST	ST	JJ	B-NP	O
depressions	depression	NNS	I-NP	O
globally	globally	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
IV	IV	CD	B-NP	O
fluids	fluid	NNS	I-NP	O
and	and	CC	O	O
750	750	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
procainamide	procainamide	NN	B-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
Cardizem	Cardizem	NNP	I-NP	O
and	and	CC	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
resolved	resolve	VBN	B-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
came	come	VBD	B-VP	O
up	up	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
110	110	CD	I-NP	O
range	range	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
rate	rate	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
80s	80	NNS	I-NP	O
.	.	.	O	O

Subsequently	Subsequently	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
converted	convert	VBD	B-VP	O
into	into	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
60s	60	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Hamren	Hamren	NNP	I-NP	O
Ry	Ry	NNP	I-NP	O
County	County	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
lasted	last	VBD	B-VP	O
for	for	IN	B-PP	O
approximately	approximately	RB	B-NP	O
one	one	CD	I-NP	O
hour	hour	NN	I-NP	O
in	in	IN	B-PP	O
total	total	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
arrival	arrival	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Nal	Nal	NNP	I-NP	O
Vervmi	Vervmi	NNP	I-NP	O
Theast	Theast	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
3	3	CD	B-NP	O
out	out	IN	I-NP	O
of	of	IN	I-NP	O
10	10	CD	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
without	without	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	I-NP	O
presyncope	presyncope	NN	I-NP	O
or	or	CC	I-NP	O
palpitations	palpitation	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
pain	pain	NN	I-NP	O
radiates	radiate	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
back	back	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
reproducible	reproducible	JJ	B-ADJP	O
with	with	IN	B-PP	O
left-sided	left-sided	JJ	B-NP	O
sternal	sternal	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
unlike	unlike	IN	B-PP	O
her	her	PRP$	B-NP	O
prior	prior	JJ	I-NP	O
anginal	anginal	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Hypertension	Hypertension	NN	I-NP	O
;	;	:	O	O
-LRB-	-LRB-	NN	B-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
High	High	NNP	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
3	3	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Coronary	Coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
on	on	IN	B-PP	O
3/4/97	3/4/97	CD	B-NP	O
with	with	IN	B-PP	O
anatomy	anatomy	NN	B-NP	O
as	as	IN	B-SBAR	O
described	describe	VBN	B-VP	O
above	above	IN	B-PP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
4	4	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Bladder	Bladder	NN	I-NP	O
suspension	suspension	NN	I-NP	O
surgery	surgery	NN	I-NP	O
in	in	IN	B-PP	O
1995	1995	CD	B-NP	O
and	and	CC	I-NP	O
1997	1997	CD	I-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
5	5	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Paroxysmal	Paroxysmal	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
perioperatively	perioperatively	RB	B-ADVP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Atenolol	Atenolol	NN	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Percocet	Percocet	NNP	I-NP	I-protein
1-2	1-2	CD	I-NP	I-protein
tabs	tab	NNS	I-NP	I-protein
p.o.	p.o.	FW	B-NP	O
q.	q.	FW	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
;	;	:	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
Coumadin	Coumadin	NN	I-NP	I-protein
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Axid	Axid	NNP	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
5	5	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
cephradine	cephradine	NN	I-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.i.d.	q.i.d.	FW	I-ADVP	O
x7	x7	CD	B-NP	O
days	day	NNS	I-NP	O
for	for	IN	B-PP	O
wound	wound	NN	B-NP	O
infection	infection	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
vein	vein	NN	I-NP	B-DNA
harvest	harvest	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
6	6	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
procainamide	procainamide	NN	I-NP	O
750	750	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.i.d.	q.i.d.	FW	I-NP	O
-LRB-	-LRB-	FW	I-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
receiving	receive	VBG	I-VP	O
500	500	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
in	in	IN	B-PP	O
hospital	hospital	NN	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
History	History	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
son	son	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
39	39	CD	I-NP	O
,	,	,	O	O
brother	brother	NN	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
64	64	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
mother	mother	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
64	64	CD	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
and	and	CC	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
smoke	smoke	VB	I-VP	O
tobacco	tobacco	NN	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
:	:	:	O	O
VITAL	VITAL	JJ	B-NP	O
SIGNS	SIGNS	NN	I-NP	O
-	-	HYPH	B-NP	O
Heart	Heart	NN	I-NP	O
rate	rate	NN	I-NP	O
59	59	CD	I-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
100/60	100/60	CD	I-NP	I-DNA
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
sat	sit	VBD	B-VP	O
98	98	CD	B-NP	O
on	on	IN	B-PP	O
three	three	CD	B-NP	O
liters	liter	NNS	I-NP	O
with	with	IN	B-PP	O
temp	temp	NN	B-NP	B-protein
97.7	97.7	CD	I-NP	I-protein
.	.	.	O	O

GENERAL	GENERAL	JJ	B-NP	O
-	-	HYPH	I-NP	O
She	She	NN	I-NP	B-protein
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
elderly	elderly	JJ	I-NP	O
woman	woman	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
Oropharynx	Oropharynx	NN	I-NP	O
is	be	VBZ	B-VP	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

NECK	NECK	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
She	She	NN	I-NP	B-protein
has	have	VBZ	B-VP	O
normal	normal	JJ	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
at	at	IN	B-PP	O
approximately	approximately	RB	B-NP	O
8	8	CD	I-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

CHEST	CHEST	NN	B-NP	O
-	-	HYPH	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
and	and	CC	I-NP	O
percussion	percussion	NN	I-NP	O
.	.	.	O	O

HEART	HEART	NN	B-NP	B-protein
-	-	HYPH	B-PP	O
Remarkable	Remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
S1	S1	NN	B-NP	B-protein
and	and	CC	I-NP	O
S2	S2	NN	I-NP	B-protein
.	.	.	O	O

Regular	Regular	JJ	B-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
surgical	surgical	JJ	I-NP	O
scar	scar	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
midline	midline	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
healing	heal	VBG	I-VP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
pus	pus	NN	I-NP	O
or	or	CC	I-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
inflammation	inflammation	NN	B-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
-	-	HYPH	I-NP	O
Benign	Benign	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
midline	midline	NN	I-NP	O
scar	scar	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
healing	heal	VBG	I-VP	O
without	without	IN	B-PP	O
erythema	erythema	NN	B-NP	O
or	or	CC	I-NP	O
pus	pus	NN	I-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NN	B-NP	O
-	-	HYPH	O	O
Revealed	Reveal	VBN	B-VP	O
a	a	DT	O	O
left	leave	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
medial	medial	JJ	I-NP	O
scar	scar	NN	I-NP	O
with	with	IN	B-PP	O
erythema	erythema	NN	B-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
pus	pus	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
left-sided	left-sided	JJ	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
shin	shin	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
side	side	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
1-2	1-2	CD	B-NP	O
+	+	SYM	B-NP	O
decreased	decrease	VBD	B-VP	O
pulses	pulse	NNS	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
feet	foot	NNS	I-NP	O
were	be	VBD	B-VP	O
cool	cool	JJ	B-ADJP	O
but	but	CC	O	O
her	her	PRP$	B-NP	O
neurologic	neurologic	JJ	I-NP	O
function	function	NN	I-NP	O
was	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
normal	normal	JJ	B-NP	O
capillary	capillary	JJ	I-NP	O
refill	refill	NN	I-NP	O
.	.	.	O	O

NEURO	NEURO	NN	B-NP	B-protein
-	-	HYPH	B-PP	O
Non-focal	Non-focal	JJ	B-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
BUN	BUN	NN	B-NP	B-DNA
18	18	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.0	1.0	CD	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
15	15	CD	I-NP	O
and	and	CC	O	O
hematocrit	hematocrit	NN	B-NP	O
40	40	CD	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
LFTs	LFT	NNS	I-NP	B-protein
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
CK	CK	NN	I-NP	B-protein
was	be	VBD	B-VP	O
55	55	CD	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
,	,	,	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
here	here	RB	B-ADVP	O
,	,	,	O	O
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
59	59	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
intervals	interval	NNS	B-NP	O
of	of	IN	B-PP	O
0.2	0.2	CD	B-NP	O
,	,	,	I-NP	O
0.08	0.08	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
484	484	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
axis	axis	NN	I-NP	O
of	of	IN	B-PP	O
-34	-34	CD	B-NP	O
degrees	degree	NNS	I-NP	O
and	and	CC	O	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
old	old	JJ	I-NP	O
inferior	inferior	JJ	I-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
T-wave	T-wave	JJ	B-NP	O
inversions	inversion	NNS	I-NP	O
in	in	IN	B-PP	O
lead	lead	NN	B-NP	O
I	I	NN	I-NP	O
,	,	,	O	O
L	L	NN	B-NP	O
,	,	,	O	O
V2-V6	V2-V6	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
II	II	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
ST	ST	JJ	B-NP	O
elevations	elevation	NNS	I-NP	O
-LRB-	-LRB-	TO	B-PP	O
slight	slight	JJ	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
in	in	IN	B-PP	O
leads	lead	NNS	B-NP	O
III	III	CD	B-NP	O
and	and	CC	O	O
F	F	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
were	be	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
upon	upon	IN	B-PP	O
arrival	arrival	NN	B-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
from	from	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
short	short	JJ	B-ADJP	O
,	,	,	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
72-year-old	72-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
grafting	graft	VBG	B-VP	O
12	12	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
now	now	RB	I-VP	O
readmitted	readmitte	VBN	I-VP	O
within	within	IN	B-PP	O
four	four	CD	B-NP	O
hours	hour	NNS	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
rapid	rapid	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
lasting	last	VBG	B-VP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
hour	hour	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
and	and	CC	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
procainamide	procainamide	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
750	750	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
given	give	VBN	B-PP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
proc/nepa	proc/nepa	NN	B-NP	O
were	be	VBD	B-VP	O
subtherapeutic	subtherapeutic	JJ	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
earlier	earlier	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
her	her	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
one	one	CD	B-NP	O
hour	hour	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
with	with	IN	B-PP	O
serial	serial	JJ	B-NP	O
CKs	CK	NNS	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
flat	flat	JJ	B-ADJP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
troponin	troponin	NN	I-NP	O
came	come	VBD	B-VP	O
back	back	RB	B-ADVP	O
at	at	IN	B-PP	O
5.1	5.1	CD	B-NP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
morning	morning	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
rapidly	rapidly	RB	B-ADVP	O
trended	trend	VBD	B-VP	O
downward	downward	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
so	so	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
unclear	unclear	JJ	B-ADJP	O
as	as	IN	B-PP	O
to	to	TO	B-PP	O
whether	whether	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
actually	actually	RB	I-VP	O
suffered	suffer	VBN	I-VP	O
any	any	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
damage	damage	NN	I-NP	O
.	.	.	O	O

Other	Other	JJ	B-NP	O
possible	possible	JJ	I-NP	O
explanations	explanation	NNS	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
included	include	VBD	B-VP	O
:	:	:	O	O
Question	Question	NN	B-NP	O
of	of	IN	B-PP	O
pericarditic	pericarditic	JJ	B-NP	O
,	,	,	I-NP	O
post-pericardiotomy	post-pericardiotomy	JJ	I-NP	O
pain	pain	NN	I-NP	O
vs.	vs.	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
disease	disease	NN	I-NP	O
vs	vs	IN	B-PP	O
non-cardiac	non-cardiac	JJ	B-NP	O
causes	cause	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
Infectious	Infectious	JJ	I-NP	O
Disease	Disease	NN	I-NP	O
issue	issue	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
some	some	DT	B-NP	O
erythema	erythema	NN	I-NP	B-DNA
around	around	IN	B-PP	I-DNA
her	her	PRP$	B-NP	I-DNA
left	left	JJ	I-NP	I-DNA
leg	leg	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
.	.	.	O	O

On	On	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
140-150	140-150	CD	B-NP	O
with	with	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
of	of	IN	B-PP	O
palpitation	palpitation	NN	B-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
proc	proc	NN	I-NP	O
and	and	CC	I-NP	O
nepa	nepa	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
therapeutic	therapeutic	JJ	B-ADJP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
6.0-9	6.0-9	CD	I-NP	I-protein
.0	.0	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
atypical	atypical	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
without	without	IN	B-PP	O
EKG	EKG	NN	B-NP	O
changes	change	NNS	I-NP	O
and	and	CC	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
different	different	JJ	B-ADJP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
prior	prior	JJ	I-NP	O
angina	angina	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
following	follow	VBG	I-NP	O
evening	evening	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
160	160	CD	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
ST-T	ST-T	NN	I-NP	O
wave	wave	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
episode	episode	NN	I-NP	O
resolved	resolve	VBN	B-VP	O
with	with	IN	B-PP	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
within	within	IN	B-PP	O
10	10	CD	B-NP	O
minutes	minute	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
11/17/97	11/17/97	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
LV	LV	NN	I-NP	O
size	size	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
concentric	concentric	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-NP	O
systolic	systolic	JJ	I-NP	O
function	function	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
66	66	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
inferior	inferior	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
.	.	.	O	O

Based	Base	VBN	B-PP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
information	information	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
probably	probably	RB	B-ADVP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
decision	decision	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
failed	fail	VBN	I-VP	O
procainamide	procainamide	NN	B-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
now	now	RB	I-VP	O
broke	broke	VB	I-VP	O
through	through	IN	B-PP	O
several	several	JJ	B-NP	O
times	time	NNS	I-NP	O
with	with	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
well	well	RB	B-ADJP	O
therapeutic	therapeutic	JJ	I-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
procainamide	procainamide	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
procainamide	procainamide	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
loaded	load	VBN	I-VP	O
on	on	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
dosage	dosage	NN	I-NP	O
of	of	IN	B-PP	O
600	600	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
t.i.d.	t.i.d.	FW	I-NP	O
x13	x13	NN	I-NP	O
doses	dose	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/10/97	10/10/97	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
ETT	ETT	NN	I-NP	B-DNA
MIBI	MIBI	NN	I-NP	I-DNA
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
mild	mild	JJ	B-NP	O
peri-infarct	peri-infarct	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
ST-T	ST-T	NN	I-NP	O
wave	wave	NN	I-NP	O
changes	change	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
at	at	IN	B-PP	O
nine	nine	CD	B-NP	O
minutes	minute	NNS	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
submax	submax	NN	I-NP	O
Bruce	Bruce	NNP	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
remained	remain	VBD	B-VP	O
on	on	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
200	200	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Anticoagulation	Anticoagulation	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
for	for	IN	B-PP	O
over	over	IN	B-NP	O
36	36	CD	I-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
other	other	JJ	I-NP	O
issues	issue	NNS	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
having	have	VBG	B-VP	O
included	include	VBN	I-VP	O
infectious	infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
cephradine	cephradine	NN	B-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
some	some	DT	B-NP	O
wound	wound	JJ	I-NP	O
site	site	NN	I-NP	O
erythema	erythema	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
elevated	elevate	VBN	I-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
at	at	IN	B-PP	O
an	an	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
five	five	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
cephradine	cephradine	NN	B-NP	O
and	and	CC	O	O
remained	remain	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
for	for	IN	B-PP	O
concern	concern	NN	B-NP	O
about	about	IN	B-PP	O
a	a	DT	B-NP	O
UTI	UTI	NN	I-NP	B-DNA
,	,	,	O	O
given	give	VBN	B-PP	O
her	her	PRP$	B-NP	O
complaints	complaint	NNS	I-NP	O
of	of	IN	B-PP	O
urinary	urinary	JJ	B-NP	O
frequency	frequency	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
more	more	RBR	B-ADJP	O
likely	likely	JJ	I-ADJP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
urinary	urinary	JJ	I-NP	O
frequency	frequency	NN	I-NP	O
is	be	VBZ	B-VP	O
related	related	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP	B-NP	O
underlying	underlie	VBG	B-VP	O
urologic	urologic	JJ	B-NP	O
problems	problem	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
IV	IV	CD	I-NP	O
heparin	heparin	NN	I-NP	O
while	while	IN	B-SBAR	O
not	not	RB	O	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
restarting	restart	VBG	I-VP	O
with	with	IN	B-PP	O
careful	careful	JJ	B-NP	O
recoumadinization	recoumadinization	NN	I-NP	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
now	now	RB	B-ADVP	O
on	on	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Aspirin	Aspirin	NN	I-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
amiodarone	amiodarone	NN	I-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
3	3	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
atenolol	atenolol	NN	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
4	4	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Isordil	Isordil	NN	I-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
5	5	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
sublingual	sublingual	JJ	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
6	6	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
7	7	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Axid	Axid	NN	I-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
-LRB-	-LRB-	NN	B-NP	O
8	8	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Ativan	Ativan	NNP	I-NP	O
0.25	0.25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
anxiety	anxiety	NN	I-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
9	9	CD	I-NP	O
-RRB-	-RRB-	SYM	O	O
Premarin	Premarin	NN	B-NP	O
0.625	0.625	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
-LRB-	-LRB-	NN	B-NP	O
10	10	CD	I-NP	O
-RRB-	-RRB-	:	O	O
Pravachol	Pravachol	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
now	now	RB	I-VP	O
been	be	VBN	I-VP	O
in	in	IN	B-PP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
for	for	IN	B-PP	O
over	over	IN	B-NP	O
36	36	CD	I-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
seems	seem	VBZ	B-VP	O
likely	likely	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
not	not	RB	I-VP	O
require	require	VB	I-VP	O
long-term	long-term	JJ	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
or	or	CC	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
FOLLOW-UP	FOLLOW-UP	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Harry	Harry	NNP	I-NP	O
Finnila	Finnila	NNP	I-NP	O
,	,	,	O	O
so	so	IN	B-SBAR	O
that	that	IN	I-SBAR	O
the	the	DT	B-NP	O
decision	decision	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
made	make	VBN	I-VP	O
as	as	IN	B-PP	O
to	to	TO	B-PP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
may	may	MD	B-VP	O
stop	stop	VB	I-VP	O
taking	take	VBG	I-VP	O
her	her	PRP$	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
and	and	CC	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
on	on	IN	B-PP	O
4/2/97	4/2/97	CD	B-NP	O
.	.	.	O	O

CONDITION	CONDITION	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
KEN	KEN	NNP	B-NP	O
MURPHY	MURPHY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
BT34	BT34	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
GREG	GREG	NNP	B-NP	O
SETTERS	SETTERS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
BC24	BC24	NNP	I-NP	O
XF715/9757	XF715/9757	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
77539	77539	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

BIRYAB6TSB	BIRYAB6TSB	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
3/1/97	3/1/97	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
2/29/97	2/29/97	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

DOUGLASS	DOUGLASS	NNP	B-NP	O
WENDY	WENDY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
BC24	BC24	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

WINFORD	WINFORD	NNP	B-NP	O
D.	D.	NNP	I-NP	O
MRAZ	MRAZ	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
JZ2	JZ2	NNP	I-NP	O

